In Silico and In Vivo Evaluation of Synthesized SCP-2 Inhibiting Compounds on Life Table Parameters of Helicoverpa armigera (Hübner).

For environment-friendly, safe and nonpersistent chemical control of a significant polyphagous insect pest, Helicoverpa armigera, discovery of growth-regulating xenobiotics can offer a sustainable alternative to conventional insecticides. For this purpose, chemically synthesized compounds to inhibit sterol carrier protein (SCP-2) function using in silico and in vivo assays were evaluated to estimate their impact on the survivals and lifetable indices of H. armigera. From nine chemically synthesized compounds, OA-02, OA-06 and OA-09 were selected for this study based on binding poses mimicking cholesterol, a natural substrate of sterol carrier protein and molecular dynamics simulations. In vivo bioassays revealed that all compounds significantly reduced the larval and pupal weight accumulations and stadia lengths. Subsequently, the pupal periods were prolonged upon treatment with higher doses of the selected compounds. Moreover, OA-09 significantly reduced pupation and adult emergence rates as well as the fertility of female moths; however, fecundity remained unaffected, in general. The life table parameters of H. armigera were significantly reduced when treated with OA-09 at higher doses. The population treated with 450 µM of OA-09 had the least net reproductive rates (Ro) and gross reproductive rate (GRR) compared to the control population. The same compound resulted in a declining survival during the early stages of development coupled with reduced larval and pupal durations, and fertility. These results have a significant implication for developing an effective and sustainable chemical treatment against H. armigera infestation.

Investigation and Discrimination of Ballpoint Pen Inks by Analytical Techniques and Chemometrics.

A population study has been performed for Pakistani ballpoint pen inks of blue, black, red, and green colors (a total of four colors) commercially used in Pakistan. Ballpoint pen inks have been investigated and discriminated by using UV/Vis spectroscopy and FTIR spectroscopy. We have calculated and compared the results in terms of discriminating power (DP). The statistical techniques of principal component analysis and cluster analysis have been applied on obtained data. By visual comparison, the best DP is obtained for green ballpoint pen inks, i.e., 0.866 by using UV/Vis spectroscopy and FTIR techniques. Black and red ballpoint pen inks showed the highest DPs by using UV/Vis spectroscopy; however, blue ballpoint pen inks got the highest DP by using FTIR spectroscopy. DP has been improved by using chemometric techniques and higher DPs are obtained as compared to visual examination.

Discrimination of Pakistani Fountain Pen Inks by Gas Chromatography-Mass Spectrometry (GC-MS).

In developing countries, the chances of fraud in written documents are comparatively high. Therefore, comparison of fountain pen inks is especially imperative in examination of forensic questioned documents. We have investigated the use of the gas chromatography-mass spectrometry technique in profiling and discrimination of fountain pen ink used in Pakistan for forensic purpose. The main purpose of this study was to discriminate different Pakistani fountain pen inks. The datum for Pakistani inks of fountain pen is not obtainable. In this research study, blue, black, and green colors fountain pen inks commercially used in Pakistan have been extracted from paper using micropunch and then investigated using the gas chromatography-mass spectrometry technique. Gas chromatography-mass spectrometry (GC-MS) was used to differentiate various brands of different colors of fountain pen inks based on their chemical composition. Molecular ion peaks for different components were obtained, and components were identified on the basis of detected ions. Results have been calculated and compared in terms of discriminating power (D.P.). The D.P. for blue, black, and green inks of fountain pen was 1.0 by using the gas chromatography-mass spectrometry technique.

Forensic Discrimination Potential of Blue, Black, Green, and Red Colored Fountain Pen Inks Commercially Used in Pakistan, by UV/Visible Spectroscopy, Thin Layer Chromatography, and Fourier Transform Infrared Spectroscopy.

Examination and comparison of fountain pen inks are very important in forensic questioned documents examination in developing countries where the chances of fraud are greater in cases of cheques, marriage papers, entry of birth and death, etc. In this study, fountain pen inks of blue, black, green, and red colours that are commercially used in Pakistan have been discriminated by UV-Vis spectroscopy, TLC, and FTIR spectroscopy. We have calculated and compared the results in terms of discriminating power. UV/Visible Spectroscopy of fountain pen inks of different brands showed different composition despite their similar colours. TLC was effectively used to differentiate between the colored components of inks. FTIR results showed that each brand could be distinguished by studying the pattern of their absorption spectra that appeared due to the presence of different functional groups. On the basis of combined results of UV-VIS, TLC, and FTIR, the DP was found from 0.73-0.8 for blue, 0.80-1.0 for black, 0.5-1.0 for green, and 1.0 for red colored fountain pen inks. Overall, this study demonstrated the elevated worth of analysis of fountain pen inks commercially used in Pakistan as the study for fountain pen inks, while not very common, remains an interesting target study.

An open-label study of tiagabine as augmentation therapy for anxiety.

BACKGROUND: At least 50% of patients with anxiety disorders experience only partial response to pharmacotherapy and require augmentation therapy. Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the CNS, and agents that modulate GABA neurotransmission have shown promise in the treatment of anxiety disorders and are often used as augmentation agents. OBJECTIVE: This study evaluated tiagabine, a selective GABA reuptake inhibitor (SGRI), as augmentation therapy. METHODS: This 8-week, open-label study enrolled patients who remained symptomatic despite adequate drug trials for treatment of anxiety symptoms. Tiagabine augmentation therapy was initiated at 4 mg/d (taken in 2 doses; one in the morning with breakfast and one in the evening with a snack) for 2 days and increased to 8 mg/d for 10 days. Dose was then adjusted according to efficacy/tolerability in increments of 2 mg every 3 days up to a maximum of 20 mg/d. Effect was assessed using the Hamilton Rating Scale for Anxiety (HAM-A), Beck Anxiety Inventory (BAI), Clinical Global Impression (CGI) scale, Pittsburgh Sleep Quality Index (PSQI), and 36-item Short-Form Health Survey (SF-36). RESULTS: Of the 18 patients enrolled, 17 were included in the efficacy analysis; one withdrew due to an adverse event prior to post-baseline assessment. Mean final dose of tiagabine was 13 mg/d. Tiagabine as augmentation therapy further reduced anxiety symptoms, as shown by significant decreases in mean HAM-A total and BAI scores at Week 8 (P<0.001). Thirteen patients (76%) responded (> or =50% reduction in HAM-A total score), and 10 patients (59%) achieved remission (HAM-A total score < or =7) at Week 8. Tiagabine improved sleep quality, with a significant reduction seen in PSQI global score at Week 8 (P=.001). Augmentation therapy with tiagabine was generally well tolerated. CONCLUSION: These preliminary findings suggest that the SGRI tiagabine may be an effective and generally well tolerated augmentation therapy in patients with anxiety who remain symptomatic despite adequate drug trials for treatment of anxiety symptoms.

"A comparison of the effectiveness of two hypnotic agents for the treatment of insomnia".

OBJECTIVE: To compare the effectiveness and tolerability of two hypnotic agents, trazadone (Desyrel) and zaleplon (Sonata) on psychiatric inpatients with insomnia. METHODS: Fifteen patients who were psychiatric inpatients were assigned openly and randomly to receive either trazodone (50-100 mg) or zaleplon (10-20 mg) doses on an "as-needed basis" and followed throughout their hospital stay. Efficacy and side effect profile were subsequently assessed. CONCLUSION: This pilot study suggests that trazodone may be a better agent to promote longer, deeper subjective quality sleep for psychiatric inpatients with insomnia in terms of effectiveness. However, tolerability was much better with zaleplon as daytime residual side effects were less.